Skip to content

Clinical trials

Bone Diseases, Metabolic trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Not applicable Clear all

283 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20042
20051
20065
20076
20085
20093
201013
20119
20127
201310
20145
201512
20167
201718
201815
201923
202015
202123
202230
202317
202423
202516
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed172
Unknown status48
Recruiting18
Not yet recruiting16
Active, not recruiting13
Terminated9
Withdrawn5
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University16
Mansoura University7
University of Erlangen-Nürnberg Medical School5
Mayo Clinic4
University of Aarhus4
Ain Shams University3
Centre Hospitalier Universitaire de Saint Etienne3
DLR German Aerospace Center3
Future University in Egypt3
Hospital Regional 1o de Octubre3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic283
Osteoporosis89
Osteoporosis, Postmenopausal16
Fractures, Bone15
Sarcopenia15
Bone Resorption8
Obesity7
Vitamin D Deficiency7
Osteoporotic Fractures6
Body Weight Changes5

Trials

Showing 76 to 100 of 283. Each trial links to its page on Pharma Observatory.

183 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.